securities fraud

Mereo BioPharma faces class action lawsuit over allegedly misleading disclosures about failed Phase 3 clinical trials. Investors claim the company concealed negative trial results.

Class action lawsuit filed against Ardent Health for allegedly misrepresenting accounting practices and collection methodologies to investors between July 2024 and November 2025.

Beyond Meat faces shareholder class action over alleged undisclosed asset impairment charges. Investors who bought stock Feb-Nov 2025 can join litigation by March 24, 2026.

Schall Law Firm launches class action against Charming Medical (MCTA) after SEC suspended trading following alleged market manipulation through social media promotion.

Class action filed against Charming Medical for alleged stock price manipulation through coordinated social media promotion. Trading suspended pending SEC investigation.

Ultragenyx faces securities lawsuit alleging misleading claims about setrusumab's efficacy. Investors must act by April 6, 2026 deadline to join class action.

Rosen Law Firm sues BlackRock TCP Capital for allegedly making false statements about investment valuations and net asset values, inflating security prices. Lead plaintiff deadline: April 6, 2026.

Class action lawsuit filed against China Liberal Education for alleged social media fraud scheme that artificially inflated stock price, causing investor losses when stock collapsed January 30.